The Serum HER-2/neu Test Video

We want to learn how the serum HER-2/neu test is helping you manage metastatic breast cancer.

Tell your Story

Serum HER-2/neu testing monitors your HER-2 status in real time

• A HER-2/neu tissue test is required to qualify for HER-2 targeted therapies, such as Herceptin® and Tykerb®.
• To establish HER-2/neu positivity, a biopsy is taken. The tissue sample is then evaluated using approved IHC or FISH testing methods to determine HER-2/neu status.

• The Serum HER-2/neu test is a simple blood test for monitoring real-time HER-2/neu status after initial metastatic breast cancer diagnosis
• The Serum HER-2/neu test is used to monitor changes in HER-2/neu levels which reflects response to treatment or disease progression
• All patients diagnosed with metastatic breast cancer should have a baseline Serum HER-2/neu established, regardless of HER-2/neu tissue status.

Your doctor will order the test from a lab, and may combine it with your routine blood work. The time it takes to get results can vary between laboratories.

Overview Page
For Laboratorians
For Physicians

The Breast Cancer Testing Registry is an independent grassroots effort to build a patient registry. Become part of the registry